18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chun, Min Young | - |
dc.contributor.author | Lee, Jongmin | - |
dc.contributor.author | Jeong, Jee Hyang | - |
dc.contributor.author | Roh, Jee Hoon | - |
dc.contributor.author | Oh, Seung Jun | - |
dc.contributor.author | Oh, Minyoung | - |
dc.contributor.author | Oh, Jungsu S. | - |
dc.contributor.author | Kim, Jae Seung | - |
dc.contributor.author | Moon, Seung Hwan | - |
dc.contributor.author | Woo, Sook-young | - |
dc.contributor.author | Kim, Young Ju | - |
dc.contributor.author | Choe, Yeong Sim | - |
dc.contributor.author | Kim, Hee Jin | - |
dc.contributor.author | Na, Duk L. | - |
dc.contributor.author | Jang, Hyemin | - |
dc.contributor.author | Seo, Sang Won | - |
dc.date.accessioned | 2022-02-25T01:49:17Z | - |
dc.date.available | 2022-02-25T01:49:17Z | - |
dc.date.issued | 2022-03 | - |
dc.identifier.issn | 0513-5796 | - |
dc.identifier.issn | 1976-2437 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/55213 | - |
dc.description.abstract | Purpose Neuroinflammation is considered an important pathway associated with several diseases that result in cognitive decline. 18F-THK5351 positron emission tomography (PET) signals might indicate the presence of neuroinflammation, as well as Alzheimer’s disease-type tau aggregates. β-amyloid (Aβ)-negative (Aβ–) amnestic mild cognitive impairment (aMCI) may be associated with non-Alzheimer’s disease pathophysiology. Accordingly, we investigated associations between 18F-THK5351 PET positivity and cognitive decline among Aβ– aMCI patients. Materials and Methods The present study included 25 amyloid PET negative aMCI patients who underwent a minimum of two follow-up neuropsychological evaluations, including clinical dementia rating-sum of boxes (CDR-SOB). The patients were classified into two groups: 18F-THK5351-positive and -negative groups. The present study used a linear mixed effects model to estimate the effects of 18F-THK5351 PET positivity on cognitive prognosis among Aβ– aMCI patients. Results Among the 25 Aβ– aMCI patients, 10 (40.0%) were 18F-THK5351 positive. The patients in the 18F-THK5351-positive group were older than those in the 18F-THK5351-negative group (77.4±2.2 years vs. 70.0±5.5 years; p<0.001). There was no difference between the two groups with regard to the proportion of apolipoprotein E ε4 carriers. Interestingly, however, the CDR-SOB scores of the 18F-THK5351-positive group deteriorated at a faster rate than those of the 18F-THK5351-negative group (B=0.003, p=0.033). Conclusion The results of the present study suggest that increased 18F-THK5351 uptake might be a useful predictor of poor prognosis among Aβ– aMCI patients, which might be associated with increased neuroinflammation (ClinicalTrials.gov NCT02656498). | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Yonsei University College of Medicine | - |
dc.title | 18F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3349/ymj.2022.63.3.259 | - |
dc.identifier.scopusid | 2-s2.0-85125020335 | - |
dc.identifier.wosid | 000758190500007 | - |
dc.identifier.bibliographicCitation | Yonsei Medical Journal, v.63, no.3, pp 259 - 264 | - |
dc.citation.title | Yonsei Medical Journal | - |
dc.citation.volume | 63 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 259 | - |
dc.citation.endPage | 264 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002810856 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | TAU | - |
dc.subject.keywordAuthor | Positron emission tomography | - |
dc.subject.keywordAuthor | mild cognitive impairment | - |
dc.subject.keywordAuthor | amyloid | - |
dc.subject.keywordAuthor | tau proteins | - |
dc.subject.keywordAuthor | inflammation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.